NEA Management Company’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

NEA Management Company’s Portfolio CMTA Stock Details CMTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,707,734	Closed	-$70.7M	–	48
2019 Q1	$70.7M	Hold	2,707,734	–	–	3.67%	9
2018 Q4	$31.8M	Buy	2,707,734 +566,037	+26%	+$7.04M	1.26%	16
2018 Q3	$23.9M	Hold	2,141,697	–	–	1.03%	24
2018 Q2	$28.2M	Hold	2,141,697	–	–	1.32%	18
2018 Q1	$32.4M	Hold	2,141,697	–	–	1.44%	17
2017 Q4	$40.6M	Hold	2,141,697	–	–	1.68%	15
2017 Q3	$36.2M	Buy	+2,141,697	New	+$35M	1.27%	17

NEA Management Company's CMTA Position: Q2 2019 in Review

NEA Management Company sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 2,707,734 shares — an estimated $70.7M sold.

NEA Management Company first reported a position in CMTA in Q3 2017 and held it in 7 quarters. The position peaked at $70.7M in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

NEA Management Company reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
NEA Management Company sold 2,707,734 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $70.7M.
NEA Management Company first reported a position in Clementia Pharmaceuticals Inc. in Q3 2017 and held it in 7 quarters.
NEA Management Company's Clementia Pharmaceuticals Inc. position peaked at $70.7M in Q1 2019.
0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on NEA Management Company's 13F filing for Q2 2019, filed 7 Aug 2019.